Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haven R Garber

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Opinion in Oncology|February 22, 2019
Integrating poly(ADP-ribose) polymerase (PARP) inhibitors in the treatment of early breast cancerHaven R Garber, Jennifer K Litton
Molecular and Cellular Therapies|June 10, 2015
Adoptive T-cell therapy for LeukemiaHaven R Garber, Asma Mirza, Elizabeth A Mittendorf, et al.
NPJ Breast Cancer|April 8, 2022
Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancerHaven R Garber, Akshara Singareeka Raghavendra, Michael Lehner, et al.
Journal of the American College of Surgeons|October 23, 2023
Long-Term Outcomes and Predictors of Response in Breast Cancer Patients with Advanced Nodal InvolvementSusie X Sun, Matthew J Piotrowski, Taiwo Adesoye, et al.
Blood|March 28, 2015
Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALLYongzhi Cui, Masahiro Onozawa, Haven R Garber, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2018
Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell ProliferationTian-Hui Yang, Lisa S St John, Haven R Garber, et al.
Surgery|July 10, 2012
Targeting the MAGE A3 antigen in pancreatic cancerAlexandria P Cogdill, Dennie T Frederick, Zachary A Cooper, et al.
Oncotarget|March 19, 2024
Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancerHaven R Garber, Sreyashi Basu, Sonali Jindal, et al.
Cytotherapy|July 6, 2016
PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemiaLisa S St John, Liping Wan, Hong He, et al.
Cytotherapy|June 7, 2016
A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cellsQing Ma, Haven R Garber, Sijie Lu, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Opinion in Oncology|February 22, 2019
Integrating poly(ADP-ribose) polymerase (PARP) inhibitors in the treatment of early breast cancerHaven R Garber, Jennifer K Litton
Molecular and Cellular Therapies|June 10, 2015
Adoptive T-cell therapy for LeukemiaHaven R Garber, Asma Mirza, Elizabeth A Mittendorf, et al.
NPJ Breast Cancer|April 8, 2022
Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancerHaven R Garber, Akshara Singareeka Raghavendra, Michael Lehner, et al.
Journal of the American College of Surgeons|October 23, 2023
Long-Term Outcomes and Predictors of Response in Breast Cancer Patients with Advanced Nodal InvolvementSusie X Sun, Matthew J Piotrowski, Taiwo Adesoye, et al.
Blood|March 28, 2015
Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALLYongzhi Cui, Masahiro Onozawa, Haven R Garber, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2018
Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell ProliferationTian-Hui Yang, Lisa S St John, Haven R Garber, et al.
Surgery|July 10, 2012
Targeting the MAGE A3 antigen in pancreatic cancerAlexandria P Cogdill, Dennie T Frederick, Zachary A Cooper, et al.
Oncotarget|March 19, 2024
Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancerHaven R Garber, Sreyashi Basu, Sonali Jindal, et al.
Cytotherapy|July 6, 2016
PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemiaLisa S St John, Liping Wan, Hong He, et al.
Cytotherapy|June 7, 2016
A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cellsQing Ma, Haven R Garber, Sijie Lu, et al.
Pageof 2